United Therapeutics Corporation (UTHR) Reports First Quarter 2013 Financial Results
4/25/2013 7:22:09 AM
More...
|
United Therapeutics Corporation (UTHR) to Announce First Quarter 2013 Financial Results Before Market Open on Thursday, April 25, 2013
4/18/2013 6:46:01 AM
More...
|
United Therapeutics Corporation (UTHR) Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension
4/11/2013 2:04:56 PM
More...
|
United Therapeutics Corporation (UTHR) Falls After Hypertension Pill Rejected
3/25/2013 8:24:22 AM
More...
|
United Therapeutics Corporation (UTHR) Moves Forward Towards a Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension
2/26/2013 11:13:34 AM
More...
|
United Therapeutics Corporation (UTHR) Reports 2012 Fourth Quarter and Annual Financial Results
2/26/2013 6:19:37 AM
More...
|
United Therapeutics Corporation (UTHR) to Announce Fourth Quarter and Annual 2012 Financial Results Before Market Open on Tuesday, February 26, 2013
2/19/2013 6:43:47 AM
More...
|
United Therapeutics Corporation (UTHR) Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA
2/14/2013 8:44:01 AM
More...
|
United Therapeutics Corporation (UTHR) Announces Additional $420 Million Share Repurchase Program
2/4/2013 9:47:38 AM
More...
|
United Therapeutics Corporation (UTHR) Corporation Reports Third Quarter 2012 Financial Results
11/1/2012 10:07:23 AM
More...
|
|